ADAR1 Partners, LP

10% OwnerKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Apr 11, 2025
Net Buying
Open-Market Buys
$9.5M
Open-Market Sells
$0
Net Open-Market Flow
$9.5M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2025Buy(P)500K$10.33$5.2M4.3M
Apr 9, 2025Buy(P)325K$9.86$3.2M3.8M
Apr 9, 2025Buy(P)16K$9.40$154K744K
Apr 9, 2025Buy(P)19K$9.40$174K3.5M
Apr 9, 2025Buy(P)74K$10.33$768K4.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 9, 2025Other(J)74K50K
Apr 9, 2025Other(J)500K124K
Apr 9, 2025Other(J)325K624K

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-034321) within minutes of acceptance. Every field above traces to the original document. Verify it directly: